Ryusuke Nakagawa

6.6k total citations · 2 hit papers
54 papers, 5.7k citations indexed

About

Ryusuke Nakagawa is a scholar working on Immunology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Ryusuke Nakagawa has authored 54 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 26 papers in Molecular Biology and 10 papers in Organic Chemistry. Recurrent topics in Ryusuke Nakagawa's work include Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (16 papers) and Galectins and Cancer Biology (8 papers). Ryusuke Nakagawa is often cited by papers focused on Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (16 papers) and Galectins and Cancer Biology (8 papers). Ryusuke Nakagawa collaborates with scholars based in Japan, United States and Russia. Ryusuke Nakagawa's co-authors include Masaru Taniguchi, Kazuhiro Motoki, Yasuhiko Koezuka, Hitomi Ueno, Junqing Cui, Hiroshi Sato, Tetsu Kawano, Isao Toura, Yoshikatsu Kaneko and Eisuke Kondo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Ryusuke Nakagawa

54 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD1d-Restricted and TCR-Mediated Activation of V _α 14 NKT Cells by Glycosylceramides

1997 2.1k citations Kazuhiro Motoki, Ryusuke Nakagawa et al. profile →
Pivotal role of cerebral interleukin-17–producing γδT cells in the delayed phase of ischemic brain injury

2009 710 citations Takashi Shichita, Yuki Sugiyama et al. Nature Medicine profile →

Peers

Countries citing papers authored by Ryusuke Nakagawa

Since Specialization

Citations

This map shows the geographic impact of Ryusuke Nakagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryusuke Nakagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryusuke Nakagawa more than expected).

Fields of papers citing papers by Ryusuke Nakagawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryusuke Nakagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryusuke Nakagawa. The network helps show where Ryusuke Nakagawa may publish in the future.

Co-authorship network of co-authors of Ryusuke Nakagawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ryusuke Nakagawa. A scholar is included among the top collaborators of Ryusuke Nakagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryusuke Nakagawa. Ryusuke Nakagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SOCS3 in T and NKT Cells Negatively Regulates Cytokine Production and Ameliorates ConA-Induced Hepatitis 2009 ·The Journal of Immunology ·Mako Nakaya, Masayuki Hashimoto, Ryusuke Nakagawa, Yu Wakabayashi, Takuma Ishizaki, Ichiro Takada, Kyoko Komai, Hiroki Yoshida, Akihiko Yoshimura	37
2	A Major Lipid Raft Protein Raftlin Modulates T Cell Receptor Signaling and Enhances Th17-Mediated Autoimmune Responses 2009 ·The Journal of Immunology ·Kazuko Saeki, Satoru Fukuyama, Toranoshin Ayada, Mako Nakaya, Daisuke Aki, Giichi Takaesu, Toshikatsu Hanada, Yumiko Matsumura, Takashi Kobayashi, Ryusuke Nakagawa, Akihiko Yoshimura	53
3	Sprouty4 deficiency potentiates Ras‐independent angiogenic signals and tumor growth 2009 ·Cancer Science ·Koji Taniguchi, Takuma Ishizaki, Toranoshin Ayada, Yuki Sugiyama, Yu Wakabayashi, Takashi Sekiya, Ryusuke Nakagawa, Akihiko Yoshimura	37
4	Pivotal role of cerebral interleukin-17–producing γδT cells in the delayed phase of ischemic brain injury breakdown → 2009 ·Nature Medicine ·Takashi Shichita, Yuki Sugiyama, Hiroaki Ooboshi, Hiroshi Sugimori, Ryusuke Nakagawa, Ichiro Takada, Toru Iwaki, Yasunori Okada, Mitsuo Iida, J. Daniel, Yoichiro Iwakura, Akihiko Yoshimura	710
5	The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential 2009 ·Biochemical and Biophysical Research Communications ·Hiroyuki Mori, Ken Inoki, Kohsuke Masutani, Yu Wakabayashi, Kyoko Komai, Ryusuke Nakagawa, Kun‐Liang Guan, Akihiko Yoshimura	146
6	RCAI-37, 56, 59, 60, 92, 101, and 102, cyclitol and carbasugar analogs of KRN7000: Their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines 2009 ·Bioorganic & Medicinal Chemistry ·Takuya Tashiro, Ryusuke Nakagawa, Takatsugu Hirokawa, Sayo Inoue, Hiroshi Watarai, Masaru Taniguchi, Kenji Mori	21
7	A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity 2008 ·The Journal of Experimental Medicine ·Asuka Terashima, Hiroshi Watarai, Sayo Inoue, (unknown), Ryusuke Nakagawa, Koji Hase, Chiaki Iwamura, Hiroshi Nakajima, Toshinori Nakayama, Masaru Taniguchi	190
8	RCAI-17, 22, 24–26, 29, 31, 34–36, 38–40, and 88, the analogs of KRN7000 with a sulfonamide linkage: Their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines 2008 ·Bioorganic & Medicinal Chemistry ·Takuya Tashiro, (unknown), Ryusuke Nakagawa, K. Seino, Hiroshi Watarai, Yasuyuki Ishii, Masaru Taniguchi, Kenji Mori	23
9	A simple synthesis of four stereoisomers of roseoside and their inhibitory activity on leukotriene release from mice bone marrow-derived cultured mast cells 2008 ·Bioorganic & Medicinal Chemistry ·Arata Yajima, Yutaka Oono, Ryusuke Nakagawa, Tomoo Nukada, Goro Yabuta	37
10	RCAI-61, the 6′-O-methylated analog of KRN7000: its synthesis and potent bioactivity for mouse lymphocytes to produce interferon-γ in vivo 2008 ·Tetrahedron Letters ·Takuya Tashiro, Ryusuke Nakagawa, Sayo Inoue, Masao Shiozaki, Hiroshi Watarai, Masaru Taniguchi, Kenji Mori	34
11	Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes 2007 ·Clinical Immunology ·(unknown), Hiroko Abe, Ryusuke Nakagawa, Souichi Oomizu, Kota Watanabe, Nozomu Nishi, Takanori Nakamura, Akira Yamauchi, Mitsuomi Hirashima	49
12	Essential Role of Bystander Cytotoxic CD122+CD8+ T Cells for the Antitumor Immunity Induced in the Liver of Mice by α-Galactosylceramide 2004 ·The Journal of Immunology ·Ryusuke Nakagawa, Takuo Inui, (unknown), (unknown), Kazuhiro Motoki, Akira Yamauchi, Mitsuomi Hirashima, Yoshiko Habu, Hiroyuki Nakashima, Shuhji Seki	34
13	Age-Associated Augmentation of the Synthetic Ligand- Mediated Function of Mouse NK1.1 Ag+ T Cells: Their Cytokine Production and Hepatotoxicity In Vivo and In Vitro 2002 ·The Journal of Immunology ·Takuo Inui, Ryusuke Nakagawa, (unknown), Yoshiko Habu, Yuji Koike, Kazuhiro Motoki, Noritsugu Kuranaga, Masashi Fukasawa, Nariyoshi Shinomiya, Shuhji Seki	52
14	Syntheses of novel antitumor dihydroxanthone derivatives with inhibitory activity against DNA topoisomerase II 1999 ·Bioorganic & Medicinal Chemistry Letters ·Seiichi Sato, Yasuyo Suga, (unknown), Ryusuke Nakagawa, Takashi Tsuji, Ken Umemura, (unknown)	17
15	Syntheses and antitumor activity of cis-restricted combretastatins: 5-Membered heterocyclic analogues 1998 ·Bioorganic & Medicinal Chemistry Letters ·Koji Ohsumi, Toshihiro Hatanaka, Koichi Fujita, Ryusuke Nakagawa, Yumiko Fukuda, Yukio Nihei, Yasuyo Suga, Yoshihiro Morinaga, Yukio Akiyama, Takashi Tsuji	171
16	Variable gene segment-specific N-insertions at the signal joint of T-cell receptor Vβ-Dβ recombinations 1998 ·Immunology Letters ·Yasuyoshi Kanari, Ryusuke Nakagawa, Hiroshi Arakawa, Hideo Yamagishi	7
17	Novel B-ring modified combretastatin analogues: Syntheses and antineoplastic activity 1998 ·Bioorganic & Medicinal Chemistry Letters ·Toshihiro Hatanaka, Koichi Fujita, Koji Ohsumi, Ryusuke Nakagawa, Yumiko Fukuda, Yukio Nihei, Yasuyo Suga, Yukio Akiyama, Takashi Tsuji	64
18	F390B and C, New Antitumor Dihydroxanthone Derivatives Isolated from Penicillium sp. 1997 ·The Journal of Antibiotics ·Seiichi Sato, Ryusuke Nakagawa, (unknown), Yumiko Fukuda, (unknown), (unknown), Toshihiko Ando, (unknown), Takashi Tsuji	7
19	Potentiation of antitumor and antimetastatic activities of adriamycin by a novel N-alkylated dihydropyridine, AC394, and its enantiomers in colon cancer-bearing mice 1996 ·Cancer Chemotherapy and Pharmacology ·Katsuyoshi Oh‐ishi, Yoshihiro Morinaga, Koji Ohsumi, Ryusuke Nakagawa, Yasuyo Suga, Takashi Tsuji, Yukio Akiyama, Takashi Tsuruo	9
20	N-Alkylated 1,4-Dihydropyridines: New Agents to Overcome Multidrug Resistance. 1995 ·Chemical and Pharmaceutical Bulletin ·Koji Ohsumi, Kazuo Ohishi, (unknown), Ryusuke Nakagawa, Yasuyo Suga, (unknown), Yukio Akiyama, Takashi Tsuji, Takashi Tsuruo	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact